^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Synovial Sarcoma

1d
CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway. (PubMed, Am J Cancer Res)
Mechanistically, CBX3 binds directly to and SHH and prevents its ubiquitin-mediated degradation, thereby stabilizing the protein. CBX3-SHH subsequently suppresses mitochondrial oxidative metabolism, which in turn inhibits ferroptosis and facilitates EMT - ultimately promoting SS aggressiveness.
Journal
|
GLI1 (GLI Family Zinc Finger 1) • SHH (Sonic Hedgehog Signaling Molecule) • CBX3 (Chromobox 3)
6d
Revealing novel subtypes of synovial sarcoma through single cell transcriptomics. (PubMed, NPJ Syst Biol Appl)
The biphasic EPCAM+ SyS has the highest levels of differentiation and lowest levels of the core oncogenic program. Our data complements the traditional classification of SyS and suggests that the monophasic mesenchymal SyS might consist of two molecular subtypes.
Journal
|
EPCAM (Epithelial cell adhesion molecule) • HOXD11 (Homeobox D11) • SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex)
8d
Primary Cardiac Synovial Sarcoma (PCSS): Clinicopathologic Features of 6 Cases and Literature Comparison. (PubMed, Cardiol Res Pract)
All patients underwent surgical intervention (tumor excision) followed by adjuvant chemotherapy with doxorubicin and ifosfamide. This case series highlights the clinicopathologic and molecular features of PCSS. Overall, SS18 (SYT) gene rearrangement and TLE1 expression are crucial diagnostic markers for differentiating PCSS from other neoplasms.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • VIM (Vimentin) • SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex) • SSX1 (SSX Family Member 1)
|
doxorubicin hydrochloride • ifosfamide
8d
Phase classification
|
SSTR (Somatostatin Receptor)
|
SSTR positive
|
Lynparza (olaparib) • Lutathera (lutetium Lu 177 dotatate)
13d
Monophasic Synovial Sarcoma in an Adolescent: A Great Mimicker of Benign Pathology. (PubMed, J Indian Assoc Pediatr Surg)
This case highlights the importance of maintaining a high index of suspicion for malignancy in deep-seated soft-tissue tumors. Early diagnosis, complete surgical removal, and multimodal therapy are crucial for the management of SS.
Journal
|
BCL2 (B-cell CLL/lymphoma 2)
13d
Moderate to high-risk primary malignant solitary fibrous tumor of the kidney: a clinicopathological and molecular analysis of five cases (PubMed, Zhonghua Bing Li Xue Za Zhi)
Extensive sampling, careful morphological observation, immunohistochemical staining and molecular detection of NAB2::STAT6 fusion are helpful for the diagnosis. It appears to have aggressive biological behaviors.
Journal
|
MDM2 (E3 ubiquitin protein ligase) • BCOR (BCL6 Corepressor) • CD34 (CD34 molecule) • STAT6 (Signal transducer and activator of transcription 6) • PAX8 (Paired box 8) • SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex) • NAB2 (NGFI-A Binding Protein 2)
15d
Gastric synovial sarcoma: the critical role of molecular techniques in diagnosis of an ultra-rare cancer. (PubMed, BMJ Case Rep)
No recurrence was noted at 6-month follow-up. This case underscores the diagnostic challenge of GSS, the critical role of molecular techniques and the efficacy of minimally invasive surgical management.
Journal
|
SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex) • SSX1 (SSX Family Member 1)
17d
Primary Synovial Sarcoma of the Breast Initially Mimicking Dermatofibrosarcoma Protuberans: A Case Report. (PubMed, Eur J Breast Health)
Surgical margins were negative, and one-year follow-up showed that the patient remained disease-free. This case highlights the importance of immunohistochemistry and molecular testing for accurate diagnosis and appropriate management.
Journal
|
BCL2 (B-cell CLL/lymphoma 2) • CD34 (CD34 molecule) • SSX1 (SSX Family Member 1)
17d
Primary cardiac synovial sarcoma presenting with right heart failure and superior vena cava syndrome: a multimodal case report. (PubMed, Int J Surg Case Rep)
Early diagnosis, surgical resection, and adjuvant therapy can lead to significant symptomatic relief and may improve survival. This case highlights the value of integrating molecular diagnostics into the routine evaluation of rare cardiac tumors.
Journal
|
SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex)
19d
Small Round Cell Tumors of Soft Tissue and Skeleton in Children and Youth: A Narrative and TruSight-Based Illustrative Review of Diagnostic Cases. (PubMed, Adv Anat Pathol)
Immunohistochemistry plays a crucial role in interpreting a specific diagnosis or narrowing the differential diagnosis of SRCTs. Molecular genetic investigations are essential, particularly in cases exhibiting atypical or overlapping histologic and immunohistological features.
Journal
|
BCOR (BCL6 Corepressor) • EWSR1 (EWS RNA Binding Protein 1)
20d
Fulminant growth of primary pericardial synovial sarcoma despite partial resection: a case report. (PubMed, Eur Heart J Case Rep)
She received one cycle of anthracycline-ifosfamide chemotherapy but developed airway compromise and died on hospital day 34. This case illustrates the rapid progression and poor prognosis of primary pericardial synovial sarcoma, emphasizing that early recognition with multimodality imaging and timely surgical evaluation are crucial, as unresectable disease carries poor outcomes with current systemic therapies.
Journal
|
SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex)
|
ifosfamide
21d
Cooperative roles of class IA PI3K isoforms in translocation-related sarcoma cell survival and proliferation. (PubMed, Cancer Res Commun)
These findings suggest that PI3Kα is the dominant isoform, whereas PI3Kβ and PI3Kδ cooperate with PI3Kα in cell survival, which appears to be a characteristic feature of TRS cells. Thus, triple-isoform inhibition might represent an effective therapy for TRSs.
Journal
|
PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PIK3CD (Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta) • PIK3CB (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta)
|
PIK3CA mutation